Ludia s.r.o.

The research at Ludia s.r.o. concentrates on improving health outcomes for patients with type 2 diabetes and related metabolic disorders.

• Evaluation of new combination therapy for glycemic control
• Assessment of weight management strategies alongside basal insulin
• Investigation of patient‑reported outcomes in diabetes care

The site partners with local investigators to test innovative treatments that could lower blood sugar and support weight loss.

Clinical studies focus on individuals with obesity, including those also living with type 2 diabetes, to explore effective weight‑reduction approaches.

• Comparison of dual‑agonist regimens for body‑weight reduction
• Integration of reduced‑calorie diet and physical activity with medication
• Long‑term safety and efficacy monitoring of weight‑loss therapies

The goal is to identify therapies that achieve meaningful weight loss while maintaining metabolic health.